Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

According to the letter, the violations were related to Globus Medical’s (GMED) Class II Excelsius GPS (EGPS) surgical robot ...

Analyst Ryan Zimmerman from BTIG maintained a Buy rating on Globus ... joint robotic space. While the immediate impact of ExcelsiusFlex is downplayed in favor of focusing on the Spine segment ...

Globus Medical is acquiring Nevro Corp, a spinal cord stimulator company, according to a Feb. 6 news release. Globus Medical's transaction will include all shares of Nevro, which are valued at about ...

Hospitals and practices have bolstered their surgical offerings with spine and orthopedic robots in January. Note: This is not an exhaustive list. 1. Jonesboro, Ark.-based NEA Baptist added the Mako ...

The spinal surgical robots market is experiencing rapid growth as healthcare facilities worldwide adopt robotic-assisted technologies for spine surgeries. These robots enhance precision, reduce ...

Following strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation (SCS) company Nevro for $250m to reinforce its position in the ...